Medical oncologist Larry Norton of Memorial Sloan-Kettering Cancer Center explains how new information about the biology of breast cancer is paving the way for a more targeted approach to chemotherapy for breast cancer. Advances in the field of molecular genetics have shown that breast cancer can be caused by several genetic mutations. Researchers are using this information to develop more effective therapies that target these genes.
No comments:
Post a Comment